ALLERGIC RHINOCONJUNCTIVITIS TO BIRCH POLLEN

Clinical trials for ALLERGIC RHINOCONJUNCTIVITIS TO BIRCH POLLEN explained in plain language.

Never miss a new study

Get alerted when new ALLERGIC RHINOCONJUNCTIVITIS TO BIRCH POLLEN trials appear

Sign up with your email to follow new studies for ALLERGIC RHINOCONJUNCTIVITIS TO BIRCH POLLEN, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

Immune-Calming drug tested for seasonal allergy relief

Symptom relief Completed

This study tested whether a low-dose immune system drug called IL-2 could reduce allergy symptoms in people sensitive to birch pollen. Twenty-four adults with confirmed birch pollen allergy received either the drug or a placebo for 36 days. Researchers measured changes in nasal c…

Matched conditions: ALLERGIC RHINOCONJUNCTIVITIS TO BIRCH POLLEN

Phase: PHASE2 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Symptom relief

Last updated Mar 30, 2026 14:31 UTC

ALLERGIC RHINOCONJUNCTIVITIS TO BIRCH POLLEN

Get alerted when new ALLERGIC RHINOCONJUNCTIVITIS TO BIRCH POLLEN trials appear

Immune-Calming drug tested for seasonal allergy relief